4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-007396
Chief Financial Officer acquired 18,691 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alam Kamran Chief Financial Officer | 2023-02-02 | Grant or award | +18,691 | 284,812 | D | ||
| Derivatives | |||||||
| Alam Kamran Chief Financial Officer | 2023-02-02 | Grant or award · Employee Stock Option (right to buy) | +37,384 | 37,384 | D | ||
| Alam Kamran Chief Financial Officer | 2023-02-02 | Grant or award · Employee Stock Option (right to buy) | +149,900 | 149,900 | D | ||
Loading xslF345X03/doc4.xml…